www.nutritionj.com

Table 2
Study arm calcium intakes, phosphate doses, urine calcium and calcium balance
Study	n	Phosphate dose (mmol/day)	Phosphate source	Calcium Intake (mmol/day)	Days on Calcium intake*	Days on each balance study after adaption**	Change uCalcium (mmol/day)	Change Calcium balance (mmol/day)

Patton [21]	18	10	Na₂HPO₄& Na glycerophosphate	9	7	7	-0.4	-0.2

Patton [21]	18	19	"	9	7	7	-1.0	0.6

Patton [21]	18	10	"	24	7	7	-0.4	-0.6

Patton [21]	18	19	"	24	7	7	-1.5	0.3

Patton [21]	18	10	"	39	7	7	-1.0	0.03

Patton [21]	18	19	"	39	7	7	-0.4	1.1

Malm [27]	4	24	H₃PO₄	-	98	7	-0.9	n/a

Malm [27]	2	32	H₃PO₄	11	98	28	-0.7	0.7

Malm [27]	4	26	H₃PO₄	20	98	28	-0.9	0.1

Malm [27]	2	19	H₃PO₄	13	56	56	-1	0.03

Goldsmith [28]	7(4)	32	K₂H & KH₂	21	7	4	-0.9	0.45

Bell [29]	5	37	Na PolyP	18	6	22	-1.7	n/a

Spencer [30]	10	37	Naglycerophosphate	5	0	22	-0.8	0.03

Spencer [30]	8	37	Naglycerophosphate	21	0	40	-1.7	0.70

Spencer [30]	3	39	Naglycerophosphate	36	0	34	-2.3	-0.35

Spencer [30]	6	36	Naglycerophosphate	50	0	31	-2.1	0.10

Hegsted [31]	8	49	KH+PO+	13	0	12	-2.5	0.94

Zemel [32]	8	32	KH₂PO₄	10	2	11	-2.0	2.7

Zemel [32]	8	32	(NaPO₃)₆	10	2	11	-2.0	1.3

Schuette [33]	8	25	KH₂PO₄	15	2	6	-0.9	0.03

Spencer [34]	1	35	Naglycerophosphate	6	0	66	-3.2	0.5

Spencer [34]	4	34	Naglycerophosphate	20	0	42	-3.0	1.3

Spencer [34]	2	41	Naglycerophosphate	34	0	33	-3.6	0.00

Spencer [34]	3	40	Naglycerophosphate	51	0	40	-3.5	0.2

Whybro [36]	9	32	NaH₂PO₄	25	5	2	-1.1	n/a

Whybro [36]	11	48	Not stated	25	5	9	-2.4	n/a

Kemi [37]	14	8	Na₂Na₃HPO₄	6	0	1	-0.2	n/a

Kemi [37]	14	24	Na₂Na₃HPO₄	6	0	1	-0.5	n/a

Kemi [37]	14	48	Na₂Na₃HPO₄	6	0	1	-0.5	n/a

Krapf [35]	6	9.6	IV PO4 vs Cl	35	4	3	-3.5	n/a

* days on calcium intake prior to the measurement of outcomes ** the shortest number of days on the balance study is reported if it varied within the comparison interventions
Fenton et al. Nutrition Journal 2009 8:41 doi:10.1186/1475-2891-8-41

Table 2